Belite Bio Financials - Benzinga

Belite Bio Inc

BLTENASDAQ

Trade with Public

Trade with Public

$167.26

-1.41-0.84%

마지막 업데이트: Sep 24, 12:50 PM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 주식 보고서

Belite Bio Financials

Belite Bio (BLTE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Belite Bio Q2 Adj. EPS $(0.54) Beats $(0.79) Estimate

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.79) by 31.65 percent. This is a 8 percent decrease over losses of $(0.50) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 20, 2026

Benzinga Insights

PRO
Belite Bio Q1 EPS $(0.45) Beats $(0.63) Estimate

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.63) by 28.57 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

PRO
Belite Bio Q4 EPS $(0.70) Misses $(0.54) Estimate

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.54) by 29.15 percent. This is a 118.75 percent decrease over losses of $(0.32) per share from the

Benzinga Newsdesk

Earnings Scheduled For March 2, 2026

Benzinga Insights

Exploring Belite Bio's Earnings Expectations

Benzinga Insights

© 2026 Benzinga | All Rights Reserved